Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2020 | LEAP-004: a stepping stone for further research

Ana Maria Arance Fernandez, MD, PhD, Hospital Clinic of Barcelona, Barcelona, Spain, discusses the importance of the Phase II trial, LEAP-004 (NCT03776136). The LEAP-004 study has opened up the door for further research in this field due to a high medical need in finding new therapeutic options in patients who progress following standard-of-care treatment with anti-PD-1 based therapies. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).